| Q36834945 | Approach to the human immunodeficiency virus-infected patient with lipodystrophy |
| Q40379251 | Associations Between At-Risk Alcohol Use, Substance Use, and Smoking with Lipohypertrophy and Lipoatrophy Among Patients Living with HIV. |
| Q47310501 | Can self-reported height and weight be used among people living with HIV/AIDS? |
| Q34792983 | HIV protease inhibitors and obesity |
| Q28088839 | HIV/AIDS and lipodystrophy: implications for clinical management in resource-limited settings |
| Q36207634 | High prevalence of physical inactivity among adolescents living with HIV/Aids |
| Q35148915 | Lipodystrophy: pathophysiology and advances in treatment |
| Q38061798 | Nutrition and the HIV-associated lipodystrophy syndrome |
| Q39964157 | Nutritional and clinical status, and dietary patterns of people living with HIV/AIDS in ambulatory care in Sao Paulo, Brazil |
| Q38549900 | Outcomes and processes at a camp for youth with HIV/AIDS. |
| Q38850845 | Physical activity correlates in people living with HIV/AIDS: a systematic review of 45 studies |
| Q42225235 | Prevalence and factors associated with lipodystrophy in AIDS patients |
| Q46885023 | Socio-behavioral risk factors among older adults living with HIV in Thailand |
| Q40147168 | The effects of progressive-resisted exercises on muscle strength and health-related quality of life in persons with HIV-related poly-neuropathy in Zimbabwe |
| Q33688503 | The physical activity levels among people living with human immunodeficiency virus/acquired immunodeficiency syndrome receiving high active antiretroviral therapy in Rwanda |